Current Guidelines for Management of Medullary Thyroid Carcinoma
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from the parafollicular cells. The diagnostic and therapeutic strategies for the condition are different from those used for well-differentiated thyroid cancer. Since the 2015 American Thyroid Association guidelines for the...
Main Authors: | Mijin Kim, Bo Hyun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Academya Publishing Co.
2021-06-01
|
Series: | Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.e-enm.org/upload/pdf/enm-2021-1082.pdf |
Similar Items
-
RET Inhibitors in Non-Small-Cell Lung Cancer
by: Priscilla Cascetta, et al.
Published: (2021-09-01) -
RET Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC
by: Badi El Osta, MD, et al.
Published: (2020-09-01) -
Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives
by: Sara Fancelli, et al.
Published: (2021-03-01) -
Targeted Therapy for Medullary Thyroid Cancer: A Review
by: S. R. Priya, et al.
Published: (2017-10-01) -
Catalog of 5′ fusion partners in RET+ NSCLC Circa 2020
by: Sai-Hong Ignatius Ou, MD, PhD, et al.
Published: (2020-06-01)